Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-small-cell Lung Cancer Clinical Trial

Official title:
The Fifth Affiliated Hospital of Sun Yat-sen University

Status Completed

Clinical Trial Summary

This study is a retrospective study, screening patients with systemic PET / CT scan in our department, enrolling the ones who meet the criteria, collect their information and resting state brain PET images.Then make the brain metabolic network analysis and statistical analysis to explore the PET brain metabolic network of non-small cell lung cancer patients and the effect of chemotherapy drugs on brain metabolic network in patients with advanced lung cancer.

Clinical Trial Description

1. Enroll Participants 2. Collect PET/CT Images 3. Images Analysis 4. Statistical Analysis ;

Study Design

Related Conditions & MeSH terms

Advanced Non-small-cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Clinical Trial Details

NCT number	NCT05380908
Study type	Observational
Source	Fifth Affiliated Hospital, Sun Yat-Sen University
Contact
Status	Completed
Phase
Start date	June 1, 2017
Completion date	February 28, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05435274` - Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer	Phase 1/Phase 2
Enrolling by invitation	`NCT05192681` - Tislelizumab as Cross-line Treatment for Advanced NSCLC	Phase 2
Active, not recruiting	`NCT05499390` - AK112 in Advanced Non-Small Cell Lung Cancer	Phase 3
Not yet recruiting	`NCT04733521` - A Phase 1/2 Study of SC-43 in Combination With Cisplatin	Phase 1/Phase 2
Recruiting	`NCT04455984` - Multimodality Treatment Including Curative Resection of Advanced NSCLC
Recruiting	`NCT05904379` - AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer	Phase 1/Phase 2